Genentech, Inc. announced recently that the Phase III study BRAVO showed Lucentis (ranibizumab injection) improved vision, as measured by the primary endpoint of mean change from baseline in best-corrected visual acuity at six months, in patients with macular edema due to branch retinal vein occlusion.
Finally Food and Drug Administration(FDA) has given the permission to Allergen Inc. to sale its eye implant Ozurdex to treat macular edema.
The advent of the most recent diagnostic technique using a coherent light waves promises to revolutionize eye condition study or detection. It is compared to that with the ultrasound sonography in some ways or the other but a small technical difference. In the later sound waves are utilised for detection while in case of Optical Ocular Tomography coherent light waves are used.